DGX Quest Diagnostics Inc

  1. Stocks
  2. Healthcare
  3. NYSE: DGX

Price (delayed)

$121.86

Market cap

$13.68B

P/E Ratio

17.38

Dividend/share

$2.74

EPS

$7.01

Enterprise value

$18.51B

Quest Diagnostics is an American clinical laboratory. A Fortune 500 company, Quest operates in the United States, Puerto Rico, Mexico, and Brazil. Quest also maintains collaborative agreements with various hospitals ...

Highlights
DGX's price to earnings (P/E) is 19% higher than its 5-year quarterly average of 14.6 but 2.9% lower than its last 4 quarters average of 17.9
Quest Diagnostics's equity has increased by 3.3% from the previous quarter but it has decreased by 2.5% YoY
The net income has contracted by 46% YoY
Quest Diagnostics's quick ratio has decreased by 45% YoY and by 30% QoQ
Sector: Healthcare
Industry: Diagnostics & Research
Website: https://www.questdiagnostics.com/
Peers: LH BRLI ENZ NEO

Key stats

What are the main financial stats of DGX
Market
Shares outstanding
112.23M
Market cap
$13.68B
Enterprise value
$18.51B
Valuations
Price to earnings (P/E)
17.38
Price to book (P/B)
2.18
Price to sales (P/S)
1.44
EV/EBIT
16.12
EV/EBITDA
11.63
EV/Sales
1.95
Earnings
Revenue
$9.49B
EBIT
$1.15B
EBITDA
$1.59B
Free cash flow
$878M
Per share
EPS
$7.01
Free cash flow per share
$7.84
Book value per share
$55.79
Revenue per share
$84.71
TBVPS
$39.69
Balance sheet
Total assets
$13.43B
Total liabilities
$7.14B
Debt
$4.96B
Equity
$6.25B
Working capital
-$142M
Liquidity
Debt to equity
0.79
Current ratio
0.92
Quick ratio
0.73
Net debt/EBITDA
3.04
Margins
EBITDA margin
16.8%
Gross margin
33.6%
Net margin
8.4%
Operating margin
12.4%
Efficiency
Return on assets
6.1%
Return on equity
13%
Return on invested capital
15.6%
Return on capital employed
9.9%
Return on sales
12.1%
Dividend
Dividend yield
2.25%
DPS
$2.74
Payout ratio
39.1%

DGX stock price

How has the Quest Diagnostics stock price performed over time
Intraday
-1.21%
1 week
-1.31%
1 month
-7.96%
1 year
-2.21%
YTD
-22.1%
QTD
-13.3%

Financial performance

How have Quest Diagnostics's revenue and profit performed over time
Revenue
$9.49B
Gross profit
$3.19B
Operating income
$1.18B
Net income
$794M
Gross margin
33.6%
Net margin
8.4%
The net income has contracted by 46% YoY
DGX's operating income is down by 44% year-on-year and by 3.3% since the previous quarter
Quest Diagnostics's net margin has decreased by 40% YoY
The company's operating margin fell by 37% YoY and by 2.4% QoQ

Growth

What is Quest Diagnostics's growth rate over time

Valuation

What is Quest Diagnostics stock price valuation
DGX P/E details
P/E
17.38
P/B
2.18
P/S
1.44
EV/EBIT
16.12
EV/EBITDA
11.63
EV/Sales
1.95
DGX's EPS is down by 43% year-on-year
DGX's price to earnings (P/E) is 19% higher than its 5-year quarterly average of 14.6 but 2.9% lower than its last 4 quarters average of 17.9
The stock's price to book (P/B) is 16% less than its 5-year quarterly average of 2.6 and 16% less than its last 4 quarters average of 2.6
Quest Diagnostics's equity has increased by 3.3% from the previous quarter but it has decreased by 2.5% YoY
The stock's price to sales (P/S) is 15% less than its 5-year quarterly average of 1.7 and 10% less than its last 4 quarters average of 1.6
The revenue has contracted by 10% YoY

Efficiency

How efficient is Quest Diagnostics business performance
DGX's return on assets is down by 45% year-on-year
Quest Diagnostics's return on invested capital has decreased by 45% YoY
DGX's ROE is down by 44% year-on-year
DGX's return on sales is down by 39% year-on-year

Dividends

What is DGX's dividend history
Dividend details
DPS
$2.74
Dividend yield
2.25%
Payout ratio
39.1%
Recent dividends

Financial health

How did Quest Diagnostics financials performed over time
The total assets is 88% greater than the total liabilities
Quest Diagnostics's quick ratio has decreased by 45% YoY and by 30% QoQ
The current ratio has decreased by 40% YoY and by 31% QoQ
Quest Diagnostics's debt is 21% lower than its equity
The company's debt to equity rose by 10% YoY and by 3.9% QoQ
Quest Diagnostics's debt has increased by 7% QoQ and by 7% YoY

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.